Have a question or topic idea for The Life Science Report? Submit it here.
Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
Guests: Pete Bak and Christian Thienel
A Podcast Discussion on the Trends and Investment Activity in Radiopharmaceuticals and Psychedelics
Length: 25 minutes
Airdate: February 14, 2024
Here at Back Bay we’ve seen a number of notable trends in the radiopharmaceutical and psychedelic spaces playing out over the past couple of years. Increasingly, investors have been asking our opinions and perspectives on these topics.
Our team has written these whitepapers to address industry interest:
The Radiopharmaceutical Renaissance: Radiating Hope in Medicine
Vision of Commercial Success: Investment and Partnering Landscape for Psychedelics
In this episode, Dr. Pete Bak and Christian Thienel talk through the uptick of activity in these focus areas and discuss where the future of radiopharmaceuticals and psychedelics might be heading.
Topics in this podcast include:
A brief introduction into the history of radiation and radiopharma
Why the early promise of first-generation radiopharmaceuticals like Zevalin and Bexxar didn’t turn out to be as commercially successful
Key advancements in manufacturing and production for second-generation products like Xofigo, Lutathera and Pluvicto
The “theranostic” (therapeutic and diagnostic) potential of radiopharmaceuticals
The growing investment and R&D support for psychedelics from private companies and academics, especially with the Otsuka and Mindset acquisition for $80M in 2023
Realities within the new paradigm of novel treatments and patient/provider protocols adhering to the FDA’s Risk Evaluation and Mitigation Strategy
The evolving nature of the antibacterial space and some notable financing deals, three within two months (Antabio, Clarimedix and Revagenix)
This year on the podcast we covered a wide range of topics featuring stories from the frontline of healthcare development to the rising trends in cardiology to the transactional landscape of antibody drug conjugates. We always welcome listener questions or topics you’d like to learn more about. You can listen to previous episodes or submit your inquiries here.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher